Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$272M |
| 2 |
ExxonMobil
XOM
|
+$152M |
| 3 |
Apple
AAPL
|
+$112M |
| 4 |
Johnson & Johnson
JNJ
|
+$107M |
| 5 |
GE Aerospace
GE
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$142M |
| 2 |
NYX
NYSE EURONEXT INC
NYX
|
+$72.4M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$42.4M |
| 4 |
MOLX
MOLEX INC
MOLX
|
+$37.2M |
| 5 |
Trane Technologies
TT
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.27% |
| 2 | Technology | 13.72% |
| 3 | Healthcare | 12.85% |
| 4 | Industrials | 11.23% |
| 5 | Energy | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMN
2951
DELISTED
Imation
IMN
| $594K | ﹤0.01% |
126,935
+2,175
| +2% | +$9.46K |
|
2952
Peapack-Gladstone Financial
PGC
$800M
| $593K | ﹤0.01% |
31,078
+6,946
| +29% | +$127K |
|
|
IVAC
2953
DELISTED
Intevac Inc
IVAC
| $593K | ﹤0.01% |
79,943
+120
| +0.2% | +$728 |
|
|
ADEP
2954
DELISTED
Adept Technology Inc
ADEP
| $592K | ﹤0.01% |
35,112
+15,315
| +77% | +$156K |
|
2955
Mercantile Bank Corp
MBWM
$1.05B
| $591K | ﹤0.01% |
27,403
-809
| -3% | -$17.4K |
|
|
MSL
2956
DELISTED
Midsouth Bancorp, Inc.
MSL
| $591K | ﹤0.01% |
33,146
+300
| +0.9% | +$4.89K |
|
|
PFSW
2957
DELISTED
PFSweb, Inc.
PFSW
| $591K | ﹤0.01% |
65,173
+54
| +0.1% | +$416 |
|
2958
UFP Technologies
UFPT
$2.49B
| $590K | ﹤0.01% |
23,408
+1,712
| +8% | +$41.4K |
|
|
SIGM
2959
DELISTED
Sigma Designs Inc
SIGM
| $590K | ﹤0.01% |
125,139
-3,439
| -3% | -$18.1K |
|
2960
Galectin Therapeutics
GALT
$311M
| $588K | ﹤0.01% |
72,869
+28,484
| +64% | +$263K |
|
|
ARQL
2961
DELISTED
Arqule Inc
ARQL
| $588K | ﹤0.01% |
273,501
+4,326
| +2% | +$9.75K |
|
|
MDCI
2962
DELISTED
MEDICAL ACTION INDS INC
MDCI
| $588K | ﹤0.01% |
68,800
-18,495
| -21% | -$133K |
|
|
MSO
2963
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
| $586K | ﹤0.01% |
139,692
+27,519
| +25% | +$84.1K |
|
2964
Barclays
BCS
$93.9B
| $585K | ﹤0.01% |
+34,950
| New | +$554K |
|
2965
Enanta Pharmaceuticals
ENTA
$382M
| $582K | ﹤0.01% |
21,347
-163
| -0.8% | -$3.95K |
|
|
SKUL
2966
DELISTED
SKULLCANDY INC
SKUL
| $582K | ﹤0.01% |
80,731
+986
| +1% | +$6.01K |
|
|
NPTN
2967
DELISTED
NEOPHOTONICS CORP
NPTN
| $581K | ﹤0.01% |
82,341
+1,414
| +2% | +$9.43K |
|
|
NMRX
2968
DELISTED
Numerex Corp
NMRX
| $581K | ﹤0.01% |
44,941
+1,011
| +2% | +$12.7K |
|
|
EPZM
2969
DELISTED
Epizyme, Inc
EPZM
| $579K | ﹤0.01% |
27,838
+508
| +2% | +$14.7K |
|
|
JMP
2970
DELISTED
JMP Group LLC
JMP
| $577K | ﹤0.01% |
78,140
+15,049
| +24% | +$101K |
|
|
NBBC
2971
DELISTED
NEWBRIDGE BANCORP CLASS A COM STK (NC)
NBBC
| $577K | ﹤0.01% |
77,028
+6,957
| +10% | +$50.2K |
|
|
ARDNA
2972
DELISTED
ARDEN GROUP INC CL-A
ARDNA
| $577K | ﹤0.01% |
4,561
+268
| +6% | +$33.9K |
|
2973
Arrowhead Research
ARWR
$12.6B
| $575K | ﹤0.01% |
53,051
+5,747
| +12% | +$45.9K |
|
2974
Capital City Bank Group
CCBG
$893M
| $575K | ﹤0.01% |
48,888
+416
| +0.9% | +$4.99K |
|
|
RGLS
2975
DELISTED
Regulus Therapeutics
RGLS
| $574K | ﹤0.01% |
648
+166
| +34% | +$143K |
|
Similar funds
Geode Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Geode Capital Management held 3,826 positions worth $144B, up 16% from $125B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management deployed $6.87B of net new capital in Q4 2013, opening 169 new positions and adding to 3,008 existing holdings. Its largest new stake was Allegion: 648,283 shares worth $28.6M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Trane Technologies, an estimated $25.5M trimmed.
- Geode Capital Management's largest Q4 2013 buy was Allegion: 648,283 shares worth $28.6M.
- Geode Capital Management added most to Meta Platforms (Facebook) in Q4 2013, an estimated $272M increase.
- Geode Capital Management's biggest Q4 2013 reduction was Trane Technologies, cutting an estimated $25.5M.
- Geode Capital Management fully exited DELL INC in Q4 2013, selling an estimated $142M.
- Geode Capital Management's ten largest holdings make up 16% of its $144B portfolio in Q4 2013.
- Geode Capital Management opened 169 new positions and closed 66 in Q4 2013.
- Geode Capital Management's portfolio value rose 16% quarter-over-quarter to $144B.
Based on Geode Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.